Guanine nucleotide-binding protein G subunit alpha (G protein alpha subunit (frequently abbreviated as Gα or as Gαs, Gαi, Gαq, etc., depending on subtype))

The *Guanine nucleotide-binding protein G subunit alpha* (G protein alpha subunit) is a central component of heterotrimeric G proteins, acting as a molecular switch in cell signaling[1][2][3][8][9]. It is associated with the plasma membrane and interacts with cell surface receptors called GPCRs. Upon activation by a ligand-bound GPCR, the alpha subunit exchanges GDP for GTP, dissociates from the beta-gamma dimer, and regulates a variety of intracellular effectors, most notably adenylyl cyclase (Gαs) and phospholipase Cβ (Gαq)[1][2][3][7]. This pathway underlies many essential physiological processes, including neurotransmission, hormone response, sensory interpretation, and cell growth. There are several isoforms and splice variants of the alpha subunit, each mediating distinct downstream effects and coupling to different receptors and effectors[1][8][10]. Dysregulation or mutation of G protein alpha subunits is implicated in multiple disease states, making them key targets for therapeutic modulation[1][2][3].

Other names

G protein alpha subunitGα subunit (with specific isoforms, e.g. Gαs, Gαi, Gαq, Gα12)GTP-binding protein alpha subunitGs alpha subunit (GNAS for Gαs)Gi alpha subunitTransducin (for Gαt)Gustducin (Gαt3)

Drugs act primarily by modulating GPCR activity, which then alters Gα subunit activation state (GDP/GTP exchange) Toxins (cholera, pertussis) modify Gα subunits post-translationally to affect downstream signaling: cholera toxin locks Gαs in active state (↑cAMP); pertussis toxin prevents Gαi activation (↑cAMP)